Next Article in Journal
Investigation of the Relationship between Cardiovascular Biomarkers and Brachial–Ankle Pulse Wave Velocity in Hemodialysis Patients
Previous Article in Journal
Postoperative Analgesic Effectiveness of Peripheral Nerve Blocks in Cesarean Delivery: A Systematic Review and Network Meta-Analysis
Previous Article in Special Issue
Optic Nerve Sheath Diameter for Predicting Outcomes in Post-Cardiac Arrest Syndrome: An Updated Systematic Review and Meta-Analysis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JPM
Volume 12
Issue 4
10.3390/jpm12040635
jpm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Association between Glasgow Coma Scale in Early Carbon Monoxide Poisoning and Development of Delayed Neurological Sequelae: A Meta-Analysis

by
Myeong Namgung
1,†,
Jaehoon Oh
2,†,
Chiwon Ahn
1,*,
Chan Woong Kim
1,
Heekyung Lee
2 and
Hyunggoo Kang
2
1
Department of Emergency Medicine, College of Medicine, Chung-Ang University, Seoul 06974, Korea
2
Department of Emergency Medicine, College of Medicine, Hanyang University, Seoul 04763, Korea
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
J. Pers. Med. 2022, 12(4), 635; https://doi.org/10.3390/jpm12040635
Submission received: 17 January 2022 / Revised: 29 March 2022 / Accepted: 13 April 2022 / Published: 14 April 2022
(This article belongs to the Special Issue Personalized Medicine in Emergency and Intensive Care)
Browse Figures
Versions Notes

Abstract

:
A significant number of people experience delayed neurologic sequelae after acute carbon monoxide (CO) poisoning. The Glasgow Coma Scale (GCS) can be used to predict delayed neurologic sequelae occurrence efficiently and without any restrictions. Here, we investigated the association between a low GCS score observed in cases of early CO poisoning and delayed neurologic sequelae development through a meta-analysis. We systematically searched MEDLINE, EMBASE, and the Cochrane Library for studies on GCS as a predictor of delayed neurologic sequelae occurrence in patients with CO poisoning in June 2021. Two reviewers independently extracted study characteristics and pooled data. We also conducted subgroup analyses for the cutoff point for GCS. To assess the risk of bias of each included study, we used the quality in prognosis studies tool. We included 2328 patients from 10 studies. With regard to patients with acute CO poisoning, in the overall pooled odds ratio (OR) of delayed neurologic sequelae development, those with a low GCS score showed a significantly higher value and moderate heterogeneity (OR 2.98, 95% confidence interval (CI) 2.10–4.23, I2 = 33%). Additionally, in subgroup analyses according to the cutoff point of GCS, the development of delayed neurologic sequelae was still significantly higher in the GCS < 9 group (OR 2.80, 95% CI 1.91–4.12, I2 = 34%) than in the GCS < 10 or GCS < 11 groups (OR 4.24, 95% CI 1.55–11.56, I2 = 48%). An initial low GCS score in patients with early CO poisoning was associated with the occurrence of delayed neurologic sequelae. Additionally, GCS was quickly, easily, and accurately assessed. It is therefore possible to predict delayed neurologic sequelae and establish an active treatment strategy, such as hyperbaric oxygen therapy, to minimize neurological sequelae using GCS.

1. Introduction

Carbon monoxide (CO) poisoning is one of the major causes of both intentional and unintentional morbidity and mortality [1]. In the United States, approximately 50,000 people with CO poisoning visit the emergency department and over 400 of them die each year [2]. Additionally, according to the statistics of the Health Insurance Review & Assessment Service, more than 4000 cases of CO poisoning occur annually in South Korea [3].
The main pathophysiological mechanism of acute CO poisoning is hypoxia caused by compromised oxygen delivery. As inhaled CO, which has 200 times greater affinity for hemoglobin compared to oxygen, binds with hemoglobin to form carboxyhemoglobin, its oxygen-carrying capacity decreases [4]. The acute symptoms of CO poisoning range from nonspecific headache, dizziness, nausea, vomiting, and general malaise to altered mental status [5]. Patients with partial CO poisoning, after apparent recovery from acute symptoms, can experience neurological sequelae such as poor concentration, memory problems, personality changes, psychosis, and Parkinsonism [6]. These neurologic sequelae comprise delayed neurologic sequelae and are characterized by lucid intervals of 2–40 days [7]. According to Chambers et al., cognitive sequelae occurred in 34% of patients with CO poisoning [8], and Han et al. reported the incidence of delayed neurologic sequelae as 18.8% [9]. Although most patients with delayed neurologic sequelae improved over 1 year, approximately 15–25% of patients still exhibited neurologic deficits [10,11,12]. Since a significant number of patients with CO poisoning and delayed neurologic sequelae develop permanent impairments, it is important to predict delayed neurologic sequelae occurrence early for facilitating active and aggressive treatment. Previous studies investigating serum biomarkers have identified a relationship between troponin, S-100, creatinine kinase, or neuron-specific enolase and significant changes in delayed neurologic sequelae occurrence [9,13,14,15,16,17,18,19,20]. In addition, other studies have reported abnormal lesions related to delayed neurologic sequelae occurrence after performing early brain imaging [21,22,23]. However, because some medical institutions have restricted access to these biomarkers and brain imaging and because it takes time to confirm the results, a fast and commonly available test should be considered to predict the occurrence of delayed neurologic sequelae.
Several studies have suggested that initial altered mental status is a known risk factor for delayed neurologic sequelae development and have shown that its occurrence is higher in the group with a low Glasgow Coma Scale (GCS) score [11,24,25]. GCS is easier to use clinically than other resources in the emergency room because it can be quickly and simply assessed by clinicians. In the absence of a meta-analysis of the development of delayed neurologic sequelae in patients with acute CO poisoning and an early low GCS score, we performed such an analysis here.

2. Materials and Methods

2.1. Reporting Guidelines and Protocol Registration

We based this study on the Preferred Reporting Items for Systematic reviews and Meta-analyses and the Meta-analysis of Observational Studies in Epidemiology guidelines for reporting information from observational studies [26,27]. We prospectively registered the review protocol in the PROSPERO database (CRD42021241776).

2.2. Search Strategy

Two experienced reviewers (C.A. and J.O.) systematically searched three electronic databases (MEDLINE, Embase, and the Cochrane Library) for studies on GCS as a predictor of delayed neurologic sequelae occurrence in patients with CO poisoning through June 2021. We included medical subject headings (MeSH), Embase subject headings, and text words in our search strategy. We combined the MeSH terms and free terms related to “carbon monoxide”, “carbon monoxide poisoning”, and “delayed neurological sequelae”. We present the detailed search strategy in Supplementary Table S1.

2.3. Study Selection

Two reviewers (M.N. and C.A.) independently screened the titles, abstracts, and type of each of the identified articles, excluding irrelevant studies. First, we eliminated duplicate studies. If the title, author, and the publication year of a paper were the same, we judged it as a duplicate paper. We then excluded all articles meeting the following criteria: reviews, case reports, case series, editorials, letters, comments, conference abstracts, or meta-analyses; animal studies; irrelevant populations; and inappropriate controls. Among the papers published by the same title and the same author, we judged those published in a journal and those published as a conference abstract to be different. Where two reviewers disagreed regarding study selection, the third reviewer (J.O.) intervened, and differences were discussed until consensus was reached.
Ultimately, we included studies which assessed the initial GCS score and the development of delayed neurologic sequelae in acute CO poisoning. The clinical criterion by which we included studies to diagnose delayed neurologic sequelae was the development of neurological sequelae after a lucid interval. We excluded studies that: (1) included patients younger than 18 years, (2) included patients who failed to recover from a decreased mental status (that is, suffered permanent neurologic injury) or died, and (3) non-original articles. We subsequently reviewed the full text of potentially relevant articles that met the inclusion criteria.

2.4. Data Extraction

The two reviewers independently extracted the following information from the included studies: authors, year of publication, region of study, sample size, age, sex, initial GCS score, administration of hyperbaric oxygen therapy, and development of delayed neurologic sequelae. Discrepancies between reviewers were resolved by consensus. For the GCS score—the main outcome of our study—we extracted the odds ratio. When the included studies failed to present the odds ratio, we calculated it.

2.5. Risk of Bias Individual Studies

We assessed the methodological quality of the ten included studies using the quality in prognosis studies (QUIPS) tool [28]. Two reviewers (M.N. and J.O.) assessed the included ten studies independently; any unresolved disagreements between reviewers were resolved by discussion with the third author, with blinding to authorship and journal performed independently. We analyzed publication bias using the funnel plot and Egger’s test.

2.6. Statistical Analysis

The meta-analysis investigated the association between the initial low GCS score and the occurrence of delayed neurologic sequelae in patients with CO poisoning. For dichotomous variables, we calculated the pooled odds ratio with a 95% confidence interval (CI) using a random-effects model. We estimated the proportion of between-study inconsistency using the I2 statistic to assess heterogeneity, considering I2 values of 25%, 50%, and 75% as low, moderate, and high heterogeneity, respectively [29].
We conducted planned subgroup analyses based on sample size (>100 participants), the cutoff point of GCS (GCS < 9 points versus GCS < 10 or GCS < 11 points), and the quality of included studies. We performed a sensitivity analysis using sequential removal of individual studies and subsequent determination of an overall pooled approximation for the remaining studies.
We performed a meta-analysis and quality assessment of the included studies using Review Manager version 5.4 (Cochrane Collaboration 2012, Nordic Cochrane Centre, Copenhagen, Denmark) and R (version 4.0.0, The R Foundation for Statistical Computing, Vienna, Austria) software packages “meta” (version 4.11-0) and “metaphor” (version 2.1-0), respectively, considering a p-value of <0.05 to be statistically significant. We assessed publication bias using a funnel plot and Egger’s test.

3. Results

3.1. Study Selection

Initially, we included 6323 studies and analyzed 136 papers by reviewing the title and the abstract. We excluded 126 studies because of irrelevant population (n = 15), irrelevant intervention (n = 90), irrelevant outcome (n = 17), and animal study (n = 4) (Supplementary Table S2). Finally, we included 10 eligible studies, including 2328 patients, in this analysis [1,6,9,17,19,25,30,31,32,33]. In Figure 1, we show the flow chart for identifying eligible studies.

3.2. Study Characteristics

We evaluated the initial GCS in 10 studies to predict delayed neurologic sequelae occurrence. The cutoff points of a low GCS score associated with delayed neurologic sequelae occurrence were 9, 10, and 11 in seven, two, and one studies, respectively. Eight studies were conducted in East Asia—including Korea, Japan, and Taiwan—and two studies were conducted in Italy and Egypt. Six studies were retrospective while four studies were prospective. All but one (multicenter) investigation were single-center investigations. The maximum follow-up period of the analyzed studies ranged from 6 weeks to 2 years. We summarize the characteristics of the included studies in Table 1.

3.3. Risk of Bias and Quality Assessment

We assessed the risk of bias of included studies with the QUIPS tool, evaluating all studies with low bias in three domains—including prognostic factor measurement, outcome measurement, and statistical analysis and reporting. In the domain of study attrition, because there were no studies which completely described follow-up loss or drop-out of participants during the study period, we rated all studies as unclear or high bias. We assessed studies with four or more low-bias domains in a total six domains as high-quality studies, with 6 of 10 studies reaching this benchmark [9,17,24,25,30,31]. We present details of our assessment of study quality in Supplementary Figure S1.

3.4. Main Analysis and Subgroup Analysis

Among patients with acute CO poisoning, the overall pooled odds ratio of delayed neurologic sequelae development was significantly higher in the early low GCS score group than that in the high GCS group (odds ratio 2.98, 95% CI 2.10–4.23, I2 = 33%) (Figure 2). Additionally, we performed subgroup analyses according to sample size (≥100 versus <100), comparing the cutoff points of GCS (GCS < 9 points versus GCS < 10 or GCS < 11 points) and study quality (high versus low). Although we could not completely resolve the heterogeneity of included studies, in all subgroup analyses, the development of delayed neurologic sequelae was still significantly higher in the low GCS score group (Table 2).

3.5. Publication Bias

There was no significant asymmetry in the funnel plot, and we did not observe any publication bias in the included studies based on Egger’s regression test (p = 0.1883) (Supplementary Figure S2 and Table S3).

4. Discussion

In this systematic review and meta-analysis, we confirmed that an initial low GCS score is a significant predictor for the occurrence of delayed neurologic sequelae. In particular, we identified a cutoff GCS score for patients with CO poisoning and delayed neurologic sequelae. The incidence of delayed neurologic sequelae was significantly high not only in patients with a GCS score of <9 but also in those with a GCS score of <10 or <11.
Previous studies showed that several factors—including biomarkers and brain imaging—were potential predictors for the development of delayed neurologic sequelae. However, the wider use of these test tools is limited by situational and cost constraints and there is no one optimal test to predict delayed neurologic sequelae occurrence. For example, in some studies, the consideration of the presence of loss of consciousness during the acute CO poisoning phase and a longer duration of CO exposure as predictors of delayed neurologic sequelae occurrence [1,20,22,30,34] may be inaccurate because these factors are based on historical assumptions. According to other studies on biomarkers, an elevated serum level of creatinine kinase, neuron-specific enolase, S100B protein, and copeptin were early predictors of delayed neurologic sequelae occurrence [9,15,17,20,35]. Several studies also reported that the presence of acute brain lesions on diffusion-weighted imaging was significantly associated with delayed neurologic sequelae occurrence [21,22,23]. Although these blood and brain imaging tests are useful in predicting the occurrence of delayed neurologic sequelae in patients with CO poisoning, such tests, due to equipment or cost constraints, cannot be conducted universally. Moreover, the confirmation of these test results is time consuming. Considering these aspects, the use the initial GCS to predict delayed neurologic sequelae occurrence is extremely useful because it can be quickly, easily, and accurately assessed.
Altered GCS scores and delayed neurologic sequelae occurrence during CO poisoning is associated with CO-induced hypoxia. In the early stages of CO poisoning and reperfusion injury, hypoxia induces consciousness-related changes in the central nervous system [19,36]. It produces excessive reactive oxygen species, which cause cell damage due to their oxidative power, and induces neuron demethylation and lipid peroxidation [37,38]. Through this mechanism, pathological neuronal changes are observed in patients with delayed neurologic sequelae, especially in the cerebral white matter and globus pallidus. The initial low GCS score due to CO exposure appears to be related to the subsequent delayed neurologic sequelae occurrence [9,39,40].
Previous studies have reported that the change in scores is significantly related to the exposure time to CO [30,31]. As the exposure time increases, the volume of oxygen-bound hemoglobin decreases, promoting tissue hypoxia. Therefore, the determination of the average CO exposure time for each study is important in the analysis of the results. However, since many CO exposures occur unintentionally, the patient may be unaware of the precise CO exposure time, and the accuracy of information from patients with CO poisoning who presented with a change in consciousness is limited. In each study included in this meta-analysis, information regarding the CO exposure time was unclear. Additionally, along with the CO exposure time, it is necessary to identify other factors influencing the change in consciousness. In a previous study, when patients with intentional CO poisoning were also compromised by drug use or alcohol intake, it was necessary to differentiate the potential part played by these factors in the change in consciousness [17]. Hampson et al. reported that almost one-half of patients with intentional CO poisoning had ingested one or more poisons in addition to CO [41]. Among them, ethanol was the most common and other sedative-hypnotics were sometimes taken [39]. In another study of accidental and intentional poisonings in Poland, ethanol and CO were combined in 6.2% of cases [42]. Thus, when assessing the mental status of patients with CO poisoning, drug co-ingestion must be considered. It is additionally necessary to investigate the influence of other factors on changes in the GCS scores in patients with CO poisoning.
It is important to predict delayed neurologic sequelae occurrences in advance to prevent it in patients with CO poisoning because a lucid interval precedes the development of delayed neurologic sequelae. Prior studies suggested that hyperbaric oxygen therapy is a possible method for preventing the development of delayed neurologic sequelae in patients with CO poisoning [1,6,13,43,44]. Particularly, Liao et al. reported that a longer duration from CO exposure to hyperbaric oxygen therapy was associated with a higher risk of delayed neurologic sequelae occurrence (odds ratio, 1.06; 95% CI, 1.03–1.09). Additionally, an acceptable timing for hyperbaric oxygen therapy was within 22.5 h after CO poisoning, and hyperbaric oxygen therapy administered >48 h after CO poisoning offered no benefit in terms of prevention of delayed neurologic sequelae [1]. The use of the initial GCS can provide rapid and correct confirmation of patients with a higher risk of delayed neurologic sequelae and inform and promote the immediate implementation of hyperbaric oxygen therapy.
This study had several limitations. First, it may not be appropriate to generalize our results to different healthcare systems and ethnicities, because with the exception of two, all included studies in this meta-analysis were confined to East Asia. For more generally applicable findings, data from other countries and/or ethnicities are required. Second, we limited the abstract searches to studies published in English. Extended studies may require searches for abstracts written in languages other than English in a specific area. Third, we did not perform a detailed analysis of hyperbaric oxygen therapy, which may affect delayed neurologic sequelae occurrence. Because the included studies did not clearly describe the use of hyperbaric oxygen therapy, we were unable to conduct a subgroup analysis of this treatment. Thus, our conclusions are limited because we were unable to identify any detailed methods regarding oxygen therapy and hyperbaric oxygen therapy. Finally, as mentioned earlier, we had insufficient data on CO exposure time and concomitant medications or substances that may have affected the mental status of the patients.

5. Conclusions

A low GCS score in patients with early CO poisoning was associated with delayed neurologic sequelae occurrence and could be accessed quickly and easily in the early stage of CO poisoning. In addition, it may be possible to establish an active treatment strategy, such as hyperbaric oxygen therapy, according to GCS scores to minimize neurological sequelae.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/jpm12040635/s1, Table S1: Search strategy; Table S2: List of excluded references after full-text review; Table S3: Egger’s regression test for publication bias; Figure S1: Risk of bias and quality assessment of included studies by the QUIPS tool; Figure S2: Funnel plot for publication bias.

Author Contributions

Conceptualization, M.N. and C.A.; methodology, J.O., C.W.K. and C.A.; investigation, M.N., H.L. and H.K.; data curation, M.N., J.O. and C.A.; writing—original draft preparation, M.N. and C.A.; writing—review and editing, all authors; visualization, C.A.; supervision, C.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets generated during the current study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Liao, S.C.; Mao, Y.C.; Yang, K.J.; Wang, K.C.; Wu, L.Y.; Yang, C.C. Targeting optimal time for hyperbaric oxygen therapy following carbon monoxide poisoning for prevention of delayed neuropsychiatric sequelae: A retrospective study. J. Neurol. Sci. 2019, 396, 187–192. [Google Scholar] [CrossRef] [PubMed]
  2. Sircar, K.; Clower, J.; Shin, M.K.; Bailey, C.; King, M.; Yip, F. Carbon monoxide poisoning deaths in the United States, 1999 to 2012. Am. J. Emerg. Med. 2015, 33, 1140–1145. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Mattiuzzi, C.; Lippi, G. Worldwide epidemiology of carbon monoxide poisoning. Hum. Exp. Toxicol. 2020, 39, 387–392. [Google Scholar] [CrossRef] [PubMed]
  4. Sekiya, K.; Nishihara, T.; Abe, N.; Konishi, A.; Nandate, H.; Hamada, T.; Ikemune, K.; Takasaki, Y.; Tanaka, J.; Asano, M.; et al. Carbon monoxide poisoning-induced delayed encephalopathy accompanies decreased microglial cell numbers: Distinctive pathophysiological features from hypoxemia-induced brain damage. Brain Res. 2019, 1710, 22–32. [Google Scholar] [CrossRef]
  5. Weaver, L.K. Carbon monoxide poisoning. Undersea Hyperb. Med. 2020, 47, 151–169. [Google Scholar] [CrossRef]
  6. Lin, C.H.; Su, W.H.; Chen, Y.C.; Feng, P.H.; Shen, W.C.; Ong, J.R.; Wu, M.Y.; Wong, C.S. Treatment with normobaric or hyperbaric oxygen and its effect on neuropsychometric dysfunction after carbon monoxide poisoning: A systematic review and meta-analysis of randomized controlled trials. Medicine 2018, 97, e12456. [Google Scholar] [CrossRef]
  7. Zhang, Y.; Wang, T.; Lei, J.; Guo, S.; Wang, S.; Gu, Y.; Dou, Y.; Zhuang, X. Cerebral Damage after Carbon Monoxide Poisoning: A Longitudinal Diffusional Kurtosis Imaging Study. AJNR Am. J. Neuroradiol. 2019, 40, 1630–1637. [Google Scholar] [CrossRef]
  8. Chambers, C.A.; Hopkins, R.O.; Weaver, L.K.; Key, C. Cognitive and affective outcomes of more severe compared to less severe carbon monoxide poisoning. Brain Inj. 2008, 22, 387–395. [Google Scholar] [CrossRef]
  9. Han, S.; Choi, S.; Nah, S.; Lee, S.U.; Cho, Y.S.; Kim, G.W.; Lee, Y.H. Cox regression model of prognostic factors for delayed neuropsychiatric sequelae in patients with acute. carbon monoxide poisoning: A prospective observational study. Neurotoxicology 2021, 82, 63–68. [Google Scholar] [CrossRef]
  10. Rose, J.J.; Wang, L.; Xu, Q.; McTiernan, C.F.; Shiva, S.; Tejero, J.; Gladwin, M.T. Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy. Am. J. Respir. Crit. Care Med. 2017, 195, 596–606. [Google Scholar] [CrossRef]
  11. Choi, I.S. Delayed neurologic sequelae in carbon monoxide intoxication. Arch. Neurol. 1983, 40, 433–435. [Google Scholar] [CrossRef]
  12. Bleecker, M.L. Carbon monoxide intoxication. Handb. Clin. Neurol. 2015, 131, 191–203. [Google Scholar] [CrossRef]
  13. Chan, M.Y.; Au, T.T.; Leung, K.S.; Yan, W.W. Acute carbon monoxide poisoning in a regional hospital in Hong Kong: Historical cohort study. Hong Kong Med. J. 2016, 22, 46–55. [Google Scholar] [CrossRef]
  14. Hafez, A.S.; El-Sarnagawy, G.N. S-100beta in predicting the need of hyperbaric oxygen in CO-induced delayed neurological sequels. Hum. Exp. Toxicol. 2020, 39, 614–623. [Google Scholar] [CrossRef]
  15. Park, E.; Ahn, J.; Min, Y.G.; Jung, Y.S.; Kim, K.; Lee, J.; Choi, S.C. The usefulness of the serum s100b protein for predicting delayed neurological sequelae in acute carbon monoxide poisoning. Clin. Toxicol. 2012, 50, 183–188. [Google Scholar] [CrossRef]
  16. Kudo, K.; Otsuka, K.; Yagi, J.; Sanjo, K.; Koizumi, N.; Koeda, A.; Umetsu, M.Y.; Yoshioka, Y.; Mizugai, A.; Shiga, Y.; et al. Predictors for delayed encephalopathy following acute carbon monoxide poisoning. BMC Emerg. Med. 2014, 14, 3. [Google Scholar] [CrossRef] [Green Version]
  17. Lee, H.; Kang, H.; Ko, B.S.; Oh, J.; Lim, T.H.; Cho, Y. Initial creatine kinase level as predictor for delayed neuropsychiatric sequelae associated with acute carbon monoxide poisoning. Am. J. Emerg. Med. 2021, 43, 195–199. [Google Scholar] [CrossRef]
  18. Kitamoto, T.; Tsuda, M.; Kate, M.; Saito, F.; Kamijo, Y.; Kinoshita, T. Risk factors for the delayed onset of neuropsychologic sequelae following carbon monoxide poisoning. Acute Med. Surg. 2016, 3, 315–319. [Google Scholar] [CrossRef]
  19. Gaballah, S.Z.; Elkhishin, I.A.R.; Hashim, N.A.; Hamid, O.I.A. Predictors of Delayed Neurological Sequelae after Acute Carbon Monoxide Poisoning at Zagazig University Hospitals. Zagazig J. Forensic Med. 2020, 18, 105–121. [Google Scholar] [CrossRef]
  20. Cha, Y.S.; Kim, H.; Do, H.H.; Kim, H.I.; Kim, O.H.; Cha, K.C.; Le, K.H.; Hwang, S.O. Serum neuron-specific enolase as an early predictor of delayed neuropsychiatric sequelae in patients with acute carbon monoxide poisoning. Hum. Exp. Toxicol. 2018, 37, 240–246. [Google Scholar] [CrossRef]
  21. Jeon, S.B.; Sohn, C.H.; Seo, D.W.; Oh, B.J.; Lim, K.S.; Kang, D.W.; Kim, W.Y. Acute Brain Lesions on Magnetic Resonance Imaging and Delayed Neurological Sequelae in Carbon Monoxide Poisoning. JAMA Neurol. 2018, 75, 436–443. [Google Scholar] [CrossRef] [PubMed]
  22. Kim, Y.S.; Cha, Y.S.; Kim, M.S.; Kim, H.J.; Lee, Y.S.; Youk, H.; Kim, H.I.; Kim, O.H.; Cha, K.C.; Kim, H.; et al. The usefulness of diffusion-weighted magnetic resonance imaging performed in the acute phase as an early predictor of delayed neuropsychiatric sequelae in acute carbon monoxide poisoning. Hum. Exp. Toxicol. 2018, 37, 587–595. [Google Scholar] [CrossRef] [PubMed]
  23. Nah, S.; Choi, S.; Kim, H.B.; Lee, J.; Lee, S.U.; Lee, Y.H.; Kim, K.W.; Han, S. Cerebral White Matter Lesions on Diffusion-Weighted Images and Delayed Neurological Sequelae after Carbon Monoxide Poisoning: A Prospective Observational Study. Diagnostics 2020, 10, 698. [Google Scholar] [CrossRef] [PubMed]
  24. Lin, M.S.; Lin, C.C.; Yang, C.C.; Weng, S.C.; Wang, S.M.; Chen, C.Y.; Huang, N.; Chou, Y.H. Myocardial injury was associated with neurological sequelae of acute carbon monoxide poisoning in Taiwan. J. Chin. Med. Assoc. 2018, 81, 682–690. [Google Scholar] [CrossRef]
  25. Pepe, G.; Castelli, M.; Nazerian, P.; Vanni, S.; Panta, M.D.; Gambassi, F.; Botti, P.; Missanelli, A.; Grifoni, S. Delayed neuropsychological sequelae after carbon monoxide poisoning: Predictive risk factors in the Emergency Department. A retrospective study. Scand. J. Trauma Resusc. Emerg. Med. 2011, 19, 16. [Google Scholar] [CrossRef] [Green Version]
  26. Liberati, A.; Altman, D.G.; Tetzlaff, J.; Murlow, C.; Gøtzsche, P.C.; Ioannidis, J.P.A.; Clarke, M.; Devereaux, P.J.; Kleijnen, J.; Moher, D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ 2009, 339, b2700. [Google Scholar] [CrossRef] [Green Version]
  27. Stroup, D.F.; Berlin, J.A.; Morton, S.C.; Olkin, I.; Williamson, G.D.; Rennie, D.; Moher, D.; Becker, B.J.; Sipe, T.A.; Thacker, S.B. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283, 2008–2012. [Google Scholar] [CrossRef]
  28. Hayden, J.A.; Van der Windt, D.A.; Cartwright, J.L.; Côté, P.; Bombardier, C. Assessing bias in studies of prognostic factors. Ann. Intern Med. 2013, 158, 280–286. [Google Scholar] [CrossRef]
  29. Higgins, J.P.; Thompson, S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21, 1539–1558. [Google Scholar] [CrossRef]
  30. Liao, S.C.; Mao, Y.C.; Hung, Y.M.; Lee, C.H.; Yang, C.C. Predictive Role of QTc Prolongation in Carbon Monoxide Poisoning-Related Delayed Neuropsychiatric Sequelae. Biomed. Res. Int. 2018, 2018, 2543018. [Google Scholar] [CrossRef] [Green Version]
  31. Huang, C.C.; Lee, J.C.; Lin, K.C.; Lin, H.J.; Su, S.B.; Hsu, C.C.; Guo, H.R. Exposure Duration and History of Hypertension Predicted Neurological Sequelae in Patients with Carbon Monoxide Poisoning. Epidemiology 2019, 30, S76–S81. [Google Scholar] [CrossRef]
  32. Beppu, T.; Nishimoto, H.; Fujiwara, S.; Kudo, K.; Sanjo, K.; Narumi, S.; Oikawa, H.; Onodera, M.; Ogasawara, K.; Sasaki, M. 1H-magnetic resonance spectroscopy indicates damage to cerebral white matter in the subacute phase after CO poisoning. J. Neurol. Neurosurg. Psychiatry 2011, 82, 869–875. [Google Scholar] [CrossRef]
  33. Beppu, T.; Fujiwara, S.; Nishimoto, H.; Koeda, A.; Narumi, S.; Mori, K.; Ogasawara, K.; Sasaki, M. Fractional anisotropy in the centrum semiovale as a quantitative indicator of cerebral white matter damage in the subacute phase in patients with carbon monoxide poisoning: Correlation with the concentration of myelin basic protein in cerebrospinal fluid. J. Neurol. 2012, 259, 1698–1705. [Google Scholar] [CrossRef] [Green Version]
  34. Zou, J.F.; Guo, Q.; Shao, H.; Li, B.; Du, Y.; Liu, M.; Liu, F.; Dai, L.; Lin, H.J.; Su, S.B.; et al. Lack of pupil reflex and loss of consciousness predict 30-day neurological sequelae in patients with carbon monoxide poisoning. PLoS ONE 2015, 10, e0119126. [Google Scholar] [CrossRef]
  35. Pang, L.; Wang, H.L.; Wang, Z.H.; Wu, Y.; Dong, N.; Xu, D.H.; Wang, D.W.; Xu, H.; Zhang, N. Plasma copeptin as a predictor of intoxication severity and delayed neurological sequelae in acute carbon monoxide poisoning. Peptides 2014, 59, 89–93. [Google Scholar] [CrossRef]
  36. Sönmez, F.T.; Güneş, H.; Saritaş, A.; Kandiş, H. Carbon Monoxide Poisoning: Clinical Manifestations, Consequences, Monitoring, Diagnosis and Treatment of Toxicity. Konuralp Med. J. 2015, 7, 192–198. [Google Scholar]
  37. Thom, S.R. Dehydrogenase conversion to oxidase and lipid peroxidation in brain after carbon monoxide poisoning. J. Appl. Physiol. 1992, 73, 1584–1589. [Google Scholar] [CrossRef]
  38. Thom, S.R. Leukocytes in carbon monoxide-mediated brain oxidative injury. Toxicol. Appl. Pharmacol. 1993, 123, 234–247. [Google Scholar] [CrossRef]
  39. Du, X.; Gu, H.; Hao, F.; Gao, L.; Wang, J.; Sun, C.; Zhang, H.; Ma, P.; Zhang, X.; Hu, W. Utility of brain CT for predicting delayed encephalopathy after acute carbon monoxide poisoning. Exp. Ther. Med. 2019, 17, 2682–2688. [Google Scholar] [CrossRef] [Green Version]
  40. Kim, J.H.; Chang, K.H.; Song, I.C.; Kim, K.H.; Kwon, B.J.; Kim, H.C.; Kim, J.H.; Han, M.H. Delayed encephalopathy of acute carbon monoxide intoxication: Diffusivity of cerebral white matter lesions. AJNR Am. J. Neuroradiol. 2003, 24, 1592–1597. [Google Scholar]
  41. Hampson, N.B.; Bodwin, D. Toxic CO-ingestions in intentional carbon monoxide poisoning. J. Emerg. Med. 2013, 44, 625–630. [Google Scholar] [CrossRef] [PubMed]
  42. Targosz, D.; Sancewicz-Pach, K.; Szkolnicka, B.; Mitrus, M.; Kłys, M. Frequency and pattern of poisoning in adult and adolescent Kraków population in 2003 and 1983. Przegl. Lek. 2005, 62, 446–452. [Google Scholar] [PubMed]
  43. Lo, C.P.; Chen, S.Y.; Chou, M.C.; Wang, C.Y.; Lee, K.W.; Hsueh, C.J.; Chen, C.Y.; Huang, K.L.; Huang, G.S. Diffusion-tensor MR imaging for evaluation of the efficacy of hyperbaric oxygen therapy in patients with delayed neuropsychiatric syndrome caused by carbon monoxide inhalation. Eur. J. Neurol. 2007, 14, 777–782. [Google Scholar] [CrossRef] [PubMed]
  44. Murata, M.; Suzuki, M.; Hasegawa, Y.; Nohara, S.; Kurachi, M. Improvement of occipital alpha activity by repetitive hyperbaric oxygen therapy in patients with carbon monoxide poisoning: A possible indicator for treatment efficacy. J. Neurol. Sci. 2005, 235, 69–74. [Google Scholar] [CrossRef]
Jpm 12 00635 g001 550
Figure 1. Flow diagram for identification of relevant studies.
Figure 1. Flow diagram for identification of relevant studies.
Jpm 12 00635 g001
Jpm 12 00635 g002 550
Figure 2. Forest plot for the effect of initial low Glasgow Coma Scale and occurrence of delayed neurological sequelae in carbon monoxide poisoning [1,6,9,17,19,25,30,31,32,33].
Figure 2. Forest plot for the effect of initial low Glasgow Coma Scale and occurrence of delayed neurological sequelae in carbon monoxide poisoning [1,6,9,17,19,25,30,31,32,33].
Jpm 12 00635 g002
Table
Table 1. Characteristics of studies included in systematic review and meta-analysis.
Table 1. Characteristics of studies included in systematic review and meta-analysis.
StudyRegionPeriodDesignCutoff Point of GCS
(Low GCS Score)		No. of
Patients (DNS/No DNS)		Age
(DNS/No DNS)		Male(n) (DNS/No DNS)HBOT (DNS/No DNS)Maximum Time of
Assessment of DNS
Liao et al., 2018 [30]TaiwanJanuary 2009–December 2015retrospective, single<962/40441.0 (26.0–52.0)/
32.0 (21.0–43.0)		35/19547/2326 mon
Huang et al., 2019 [31]TaiwanJanuary 2005–December 2014retrospective, single<993/29841.4 ± 14.7/
39.7 ± 14.2		55/16373/2146 wks
Liao et al., 2019 [1]TaiwanJanuary 2009–December 2015retrospective, single<948/23138.4 ± 16.1/33.3 ± 17.129/10048/2316 mon
Lin et al., 2018 [6]TaiwanJanuary 1990–December 2011retrospective, multicenter<947/59144.2 ± 12.6/34.3 ± 16.327/28438/5052 yrs
Pepe et al., 2011 [25]Italy1992–2007retrospective, single<934/10740.4 ± 15.5/41.7 ± 21.711/5311/4412 mon
Beppu 2011 [32]JapanApril 2008–March 2010prospective, single<93/2055.0 ± 26.0/54.8 ± 19.2Not reported3/206 wks
Han et al., 2021 [9]South KoreaJuly 2017–February 2020prospective, single<1038/16544.0 (34.3–57.0)/43.0 (32.0–54.0)23/11338/1656 wks
Lee et al., 2020 [17]South KoreaJanuary 2018–July 2018retrospective, single<1012/12647.0 (33.0–50.0)/36.0 (26.0–53.0)6/6912/1176 wks
Beppu 2013 [33]JapanApril 2008–February 2011prospective, single<93/1944.3 ± 13.8/38.4 ± 10.9Not reported3/196 wks
Gaballah et al., 2020 [19]EgyptJanuary 2018–December 2018prospective, single<1110/2037.0 (18.0–55.0)/23.0 (15.0–40.0)7/122/26 mon
Acronyms: GCS, Glasgow coma scale; DNS, delayed neurologic sequelae; and HBOT, hyperbaric oxygenation therapy; wks, weeks; mon, months.
Table
Table 2. Subgroup analysis for occurrence of delayed neurologic sequelae.
Table 2. Subgroup analysis for occurrence of delayed neurologic sequelae.
CharacteristicsDevelopment of DNS
nOR (95%CI)p-Value for HeterogeneityI2 (%)
All studies
All102.98 (2.10–4.23)0.1433
Sample size
≥10072.79 (1.98–3.93)0.1636
<10038.31 (2.07–33.43)0.430
Cutoff point (low GCS score group)
<972.80 (1.91–4.12)0.1734
<10 or <1134.24 (1.55–11.56)0.1548
Study quality
High62.66 (1.83–3.88)0.1440
Low44.86 (2.36–10.00)0.480
Acronyms: GCS, Glasgow coma scale; DNS, delayed neurologic sequelae; and OR, Odd ratios.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Namgung, M.; Oh, J.; Ahn, C.; Kim, C.W.; Lee, H.; Kang, H. Association between Glasgow Coma Scale in Early Carbon Monoxide Poisoning and Development of Delayed Neurological Sequelae: A Meta-Analysis. J. Pers. Med. 2022, 12, 635. https://doi.org/10.3390/jpm12040635

AMA Style

Namgung M, Oh J, Ahn C, Kim CW, Lee H, Kang H. Association between Glasgow Coma Scale in Early Carbon Monoxide Poisoning and Development of Delayed Neurological Sequelae: A Meta-Analysis. Journal of Personalized Medicine. 2022; 12(4):635. https://doi.org/10.3390/jpm12040635

Chicago/Turabian Style

Namgung, Myeong, Jaehoon Oh, Chiwon Ahn, Chan Woong Kim, Heekyung Lee, and Hyunggoo Kang. 2022. "Association between Glasgow Coma Scale in Early Carbon Monoxide Poisoning and Development of Delayed Neurological Sequelae: A Meta-Analysis" Journal of Personalized Medicine 12, no. 4: 635. https://doi.org/10.3390/jpm12040635

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop